COSOL Limited (ASX:COS)

Kronos Bio Revenue

COSOL had revenue of 57.78M AUD in the half year ending December 31, 2024, with 66.65% growth. This brings the company's revenue in the last twelve months to 110.67M, up 23.67% year-over-year. In the fiscal year ending June 30, 2024, COSOL had annual revenue of 101.95M with 35.73% growth.

• Revenue (ttm): 110.67M
• Revenue Growth: +23.67%
• P/S Ratio: 0.94
• Revenue / Employee: n/a
• Employees: n/a
• Market Cap: 103.73M

Revenue History

Fiscal Year End	Revenue	Change	Growth
Jun 30, 2024	101.95M	26.84M	35.73%
Jun 30, 2023	75.11M	26.87M	55.70%
Jun 30, 2022	48.24M	14.66M	43.65%
Jun 30, 2021	33.58M	20.85M	163.82%
Jun 30, 2020	12.73M	-902.37K	-6.62%